- call +1-201-465-4211
- email sales@mrinsights.biz
Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli
Scope of the Report:
Sepsis is a life-threatening organ dysfunction caused by an excessive host immune response to a serious infection. According to the Centers for Disease Control and Prevention (CDC), 1.6 million Americans suffered from sepsis in 2011, of which about 260,000 did not survive. PCT can play a critical role in addressing this clinical challenge and has become a key component of successful sepsis protocols across the U.S. and Europe. PCT levels increase precipitously in patients with severe bacterial infection. PCT is therefore an extremely important biomarker enabling specific differentiation between a severe bacterial infection and other causes of inflammatory reactions.
Expressed in E.coli, PCT can be used as a reagent to prepare calibrators for procalcitonin or calcitonin immunoassays.
The global procalcitonin market had reached 126.4 g in 2016 and is expected to increase reach 212.6 g by 2023. In terms of revenue, the global procalcitonin chloride market was valued 61.85 Million USD in 2016, and is estimated to be worth 92.27 Million USD by 2023. Overall, the procalcitonin products performance is positive with the global economic recovery.
The manufacture region is concentrated in USA, Europe, China and Japan, of which Europe is the largest region with the share 36.92% in 2016. The production shares of Europe, China and Japan were 23.07%, 19.12% and 6.43%.
The consumption share of North America, Europe, Asia Pacific were 26.73%, 28.27%, 35.77% in 2016. Asia Pacific is the main export region.
There are companies adding new capacities and aims at the cost and quality leadership which shall improve profitability. As the same time, companies are focusing on technological innovation, equipment upgrades, and process improvements, to reduce costs and improve quality. The competition in Procalcitonin market will become more intense.
The worldwide market for Procalcitonin (CAS 56645-65-9) is expected to grow at a CAGR of roughly 6.4% over the next five years, will reach 90 million US$ in 2024, from 62 million US$ in 2019, according to a new study.
This report focuses on the Procalcitonin (CAS 56645-65-9) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
BBI Solutions
ProSpec
Wondfo
Ningbo Medicalsystem Biotechnology
Wuhan Easy Diagnosis Biomedicine
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Nanjing Norman Biological Technology
Shanghai Medicine'nest Pharmaceutical
Kitgen
Beijing KeyGen
Beijing Apis
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Procalcitonin Antigen
Procalcitonin Antibody
Market Segment by Applications, can be divided into
Medical Industry
Scientific Research
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Procalcitonin (CAS 56645-65-9) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Procalcitonin (CAS 56645-65-9), with price, sales, revenue and global market share of Procalcitonin (CAS 56645-65-9) in 2017 and 2018.
Chapter 3, the Procalcitonin (CAS 56645-65-9) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Procalcitonin (CAS 56645-65-9) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Procalcitonin (CAS 56645-65-9) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Procalcitonin (CAS 56645-65-9) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Procalcitonin (CAS 56645-65-9) Introduction
1.2 Market Analysis by Type
1.2.1 Procalcitonin Antigen
1.2.2 Procalcitonin Antibody
1.3 Market Analysis by Applications
1.3.1 Medical Industry
1.3.2 Scientific Research
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Thermo Fisher
2.1.1 Business Overview
2.1.2 Procalcitonin (CAS 56645-65-9) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Thermo Fisher Procalcitonin (CAS 56645-65-9) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Roche Diagnostics
2.2.1 Business Overview
2.2.2 Procalcitonin (CAS 56645-65-9) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche Diagnostics Procalcitonin (CAS 56645-65-9) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 bioMerieux
2.3.1 Business Overview
2.3.2 Procalcitonin (CAS 56645-65-9) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 bioMerieux Procalcitonin (CAS 56645-65-9) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 HyTest
2.4.1 Business Overview
2.4.2 Procalcitonin (CAS 56645-65-9) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 HyTest Procalcitonin (CAS 56645-65-9) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 BBI Solutions
2.5.1 Business Overview
2.5.2 Procalcitonin (CAS 56645-65-9) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 BBI Solutions Procalcitonin (CAS 56645-65-9) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 ProSpec
2.6.1 Business Overview
2.6.2 Procalcitonin (CAS 56645-65-9) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 ProSpec Procalcitonin (CAS 56645-65-9) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Wondfo
2.7.1 Business Overview
2.7.2 Procalcitonin (CAS 56645-65-9) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Wondfo Procalcitonin (CAS 56645-65-9) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Ningbo Medicalsystem Biotechnology
2.8.1 Business Overview
2.8.2 Procalcitonin (CAS 56645-65-9) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Ningbo Medicalsystem Biotechnology Procalcitonin (CAS 56645-65-9) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Wuhan Easy Diagnosis Biomedicine
2.9.1 Business Overview
2.9.2 Procalcitonin (CAS 56645-65-9) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Wuhan Easy Diagnosis Biomedicine Procalcitonin (CAS 56645-65-9) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Snibe
2.10.1 Business Overview
2.10.2 Procalcitonin (CAS 56645-65-9) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Snibe Procalcitonin (CAS 56645-65-9) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Vazyme Biotech
2.11.1 Business Overview
2.11.2 Procalcitonin (CAS 56645-65-9) Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Vazyme Biotech Procalcitonin (CAS 56645-65-9) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Getein Biotech
2.12.1 Business Overview
2.12.2 Procalcitonin (CAS 56645-65-9) Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Getein Biotech Procalcitonin (CAS 56645-65-9) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 Hotgen Biotech
2.13.1 Business Overview
2.13.2 Procalcitonin (CAS 56645-65-9) Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Hotgen Biotech Procalcitonin (CAS 56645-65-9) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 Lumigenex
2.14.1 Business Overview
2.14.2 Procalcitonin (CAS 56645-65-9) Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Lumigenex Procalcitonin (CAS 56645-65-9) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.15 Nanjing Norman Biological Technology
2.15.1 Business Overview
2.15.2 Procalcitonin (CAS 56645-65-9) Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Nanjing Norman Biological Technology Procalcitonin (CAS 56645-65-9) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.16 Shanghai Medicine'nest Pharmaceutical
2.16.1 Business Overview
2.16.2 Procalcitonin (CAS 56645-65-9) Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Shanghai Medicine'nest Pharmaceutical Procalcitonin (CAS 56645-65-9) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.17 Kitgen
2.17.1 Business Overview
2.17.2 Procalcitonin (CAS 56645-65-9) Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Kitgen Procalcitonin (CAS 56645-65-9) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.18 Beijing KeyGen
2.18.1 Business Overview
2.18.2 Procalcitonin (CAS 56645-65-9) Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Beijing KeyGen Procalcitonin (CAS 56645-65-9) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.19 Beijing Apis
2.19.1 Business Overview
2.19.2 Procalcitonin (CAS 56645-65-9) Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Beijing Apis Procalcitonin (CAS 56645-65-9) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Procalcitonin (CAS 56645-65-9) Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Procalcitonin (CAS 56645-65-9) Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Procalcitonin (CAS 56645-65-9) Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Procalcitonin (CAS 56645-65-9) Manufacturer Market Share in 2018
3.3.2 Top 6 Procalcitonin (CAS 56645-65-9) Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Procalcitonin (CAS 56645-65-9) Market Analysis by Regions
4.1 Global Procalcitonin (CAS 56645-65-9) Sales, Revenue and Market Share by Regions
4.1.1 Global Procalcitonin (CAS 56645-65-9) Sales and Market Share by Regions (2014-2019)
4.1.2 Global Procalcitonin (CAS 56645-65-9) Revenue and Market Share by Regions (2014-2019)
4.2 North America Procalcitonin (CAS 56645-65-9) Sales and Growth Rate (2014-2019)
4.3 Europe Procalcitonin (CAS 56645-65-9) Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Procalcitonin (CAS 56645-65-9) Sales and Growth Rate (2014-2019)
4.5 South America Procalcitonin (CAS 56645-65-9) Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Procalcitonin (CAS 56645-65-9) Sales and Growth Rate (2014-2019)
5 North America Procalcitonin (CAS 56645-65-9) by Country
5.1 North America Procalcitonin (CAS 56645-65-9) Sales, Revenue and Market Share by Country
5.1.1 North America Procalcitonin (CAS 56645-65-9) Sales and Market Share by Country (2014-2019)
5.1.2 North America Procalcitonin (CAS 56645-65-9) Revenue and Market Share by Country (2014-2019)
5.2 United States Procalcitonin (CAS 56645-65-9) Sales and Growth Rate (2014-2019)
5.3 Canada Procalcitonin (CAS 56645-65-9) Sales and Growth Rate (2014-2019)
5.4 Mexico Procalcitonin (CAS 56645-65-9) Sales and Growth Rate (2014-2019)
6 Europe Procalcitonin (CAS 56645-65-9) by Country
6.1 Europe Procalcitonin (CAS 56645-65-9) Sales, Revenue and Market Share by Country
6.1.1 Europe Procalcitonin (CAS 56645-65-9) Sales and Market Share by Country (2014-2019)
6.1.2 Europe Procalcitonin (CAS 56645-65-9) Revenue and Market Share by Country (2014-2019)
6.2 Germany Procalcitonin (CAS 56645-65-9) Sales and Growth Rate (2014-2019)
6.3 UK Procalcitonin (CAS 56645-65-9) Sales and Growth Rate (2014-2019)
6.4 France Procalcitonin (CAS 56645-65-9) Sales and Growth Rate (2014-2019)
6.5 Russia Procalcitonin (CAS 56645-65-9) Sales and Growth Rate (2014-2019)
6.6 Italy Procalcitonin (CAS 56645-65-9) Sales and Growth Rate (2014-2019)
7 Asia-Pacific Procalcitonin (CAS 56645-65-9) by Country
7.1 Asia-Pacific Procalcitonin (CAS 56645-65-9) Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Procalcitonin (CAS 56645-65-9) Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Procalcitonin (CAS 56645-65-9) Revenue and Market Share by Country (2014-2019)
7.2 China Procalcitonin (CAS 56645-65-9) Sales and Growth Rate (2014-2019)
7.3 Japan Procalcitonin (CAS 56645-65-9) Sales and Growth Rate (2014-2019)
7.4 Korea Procalcitonin (CAS 56645-65-9) Sales and Growth Rate (2014-2019)
7.5 India Procalcitonin (CAS 56645-65-9) Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Procalcitonin (CAS 56645-65-9) Sales and Growth Rate (2014-2019)
8 South America Procalcitonin (CAS 56645-65-9) by Country
8.1 South America Procalcitonin (CAS 56645-65-9) Sales, Revenue and Market Share by Country
8.1.1 South America Procalcitonin (CAS 56645-65-9) Sales and Market Share by Country (2014-2019)
8.1.2 South America Procalcitonin (CAS 56645-65-9) Revenue and Market Share by Country (2014-2019)
8.2 Brazil Procalcitonin (CAS 56645-65-9) Sales and Growth Rate (2014-2019)
8.3 Argentina Procalcitonin (CAS 56645-65-9) Sales and Growth Rate (2014-2019)
8.4 Colombia Procalcitonin (CAS 56645-65-9) Sales and Growth Rate (2014-2019)
9 Middle East and Africa Procalcitonin (CAS 56645-65-9) by Countries
9.1 Middle East and Africa Procalcitonin (CAS 56645-65-9) Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Procalcitonin (CAS 56645-65-9) Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Procalcitonin (CAS 56645-65-9) Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Procalcitonin (CAS 56645-65-9) Sales and Growth Rate (2014-2019)
9.3 Turkey Procalcitonin (CAS 56645-65-9) Sales and Growth Rate (2014-2019)
9.4 Egypt Procalcitonin (CAS 56645-65-9) Sales and Growth Rate (2014-2019)
9.5 Nigeria Procalcitonin (CAS 56645-65-9) Sales and Growth Rate (2014-2019)
9.6 South Africa Procalcitonin (CAS 56645-65-9) Sales and Growth Rate (2014-2019)
10 Global Procalcitonin (CAS 56645-65-9) Market Segment by Type
10.1 Global Procalcitonin (CAS 56645-65-9) Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Procalcitonin (CAS 56645-65-9) Sales and Market Share by Type (2014-2019)
10.1.2 Global Procalcitonin (CAS 56645-65-9) Revenue and Market Share by Type (2014-2019)
10.2 Procalcitonin Antigen Sales Growth and Price
10.2.1 Global Procalcitonin Antigen Sales Growth (2014-2019)
10.2.2 Global Procalcitonin Antigen Price (2014-2019)
10.3 Procalcitonin Antibody Sales Growth and Price
10.3.1 Global Procalcitonin Antibody Sales Growth (2014-2019)
10.3.2 Global Procalcitonin Antibody Price (2014-2019)
11 Global Procalcitonin (CAS 56645-65-9) Market Segment by Application
11.1 Global Procalcitonin (CAS 56645-65-9) Sales Market Share by Application (2014-2019)
11.2 Medical Industry Sales Growth (2014-2019)
11.3 Scientific Research Sales Growth (2014-2019)
12 Procalcitonin (CAS 56645-65-9) Market Forecast (2019-2024)
12.1 Global Procalcitonin (CAS 56645-65-9) Sales, Revenue and Growth Rate (2019-2024)
12.2 Procalcitonin (CAS 56645-65-9) Market Forecast by Regions (2019-2024)
12.2.1 North America Procalcitonin (CAS 56645-65-9) Market Forecast (2019-2024)
12.2.2 Europe Procalcitonin (CAS 56645-65-9) Market Forecast (2019-2024)
12.2.3 Asia-Pacific Procalcitonin (CAS 56645-65-9) Market Forecast (2019-2024)
12.2.4 South America Procalcitonin (CAS 56645-65-9) Market Forecast (2019-2024)
12.2.5 Middle East and Africa Procalcitonin (CAS 56645-65-9) Market Forecast (2019-2024)
12.3 Procalcitonin (CAS 56645-65-9) Market Forecast by Type (2019-2024)
12.3.1 Global Procalcitonin (CAS 56645-65-9) Sales Forecast by Type (2019-2024)
12.3.2 Global Procalcitonin (CAS 56645-65-9) Market Share Forecast by Type (2019-2024)
12.4 Procalcitonin (CAS 56645-65-9) Market Forecast by Application (2019-2024)
12.4.1 Global Procalcitonin (CAS 56645-65-9) Sales Forecast by Application (2019-2024)
12.4.2 Global Procalcitonin (CAS 56645-65-9) Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Procalcitonin (CAS 56645-65-9) Picture
Table Product Specifications of Procalcitonin (CAS 56645-65-9)
Figure Global Sales Market Share of Procalcitonin (CAS 56645-65
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
